CT News and Research

RSS

GE Healthcare to highlight advanced portfolio of molecular imaging technologies at SNM meeting

Investing and innovating in ways that break through cost, quality and access barriers to health for individuals and entire health systems, GE Healthcare is highlighting an advanced portfolio of molecular imaging technologies at the 58th annual meeting of the Society of Nuclear Medicine (SNM), June 4-8, in San Antonio.

4 Jun 2011

Response Genetics' clinical approaches to improve cancer care to be presented at ASCO 2011

Response Genetics, Inc., a company focused on the development and sale of molecular diagnostic tests for cancer, announced today five presentations to be held during the 2011 American Society of Clinical Oncology Annual Meeting in Chicago, IL from June 3 to June 7, 2011.

4 Jun 2011

Ipilimumab and bevacizumab drugs effective in treating metatastic melanoma

A duo of drugs, each targeting a prime survival strategy of tumors, can be safely administered and are potentially more effective than either drug alone for advanced, inoperable melanomas, according to a phase 1 clinical trial led by Dana-Farber Cancer Institute investigators.

4 Jun 2011

Mild brain injury tracked using special MRI technique

According to a new study there may be an explanation of why some military personnel exposed to blasts have symptoms of brain injury even though their CT and MRI scans look normal.

2 Jun 2011

PCF funds 14 new Creativity Awards for advanced prostate cancer research

The Prostate Cancer Foundation today announced that it has funded 14 new Creativity Awards for advanced prostate cancer research. These two-year awards are designed to support innovative research ideas that have the potential to achieve breakthroughs for improved prostate cancer diagnosis and treatment.

2 Jun 2011

Adipose-derived stem cell procedure restores skull defects after brain surgery

Stem cells derived from abdominal fat—used along with a synthetic bone grafting material—are a potentially valuable new approach to repairing skull defects after brain surgery, according to a study in the June issue of Neurosurgery, official journal of the Congress of Neurological Surgeons.

2 Jun 2011

Adaptimmune announces opening of Phase I/II clinical trial in multiple myeloma

Adaptimmune announced that it has opened a Phase I/II, dual site, two-cohort, open-label clinical trial in multiple myeloma at the University of Maryland and the University of Pennsylvania testing its enhanced T cell receptor T cell therapy.

1 Jun 2011

Twelve interventional live cases to use Toshiba's Infinix DP-i X-ray system at NCVH conference

Enabling physicians to perform a range of interventional procedures, Toshiba America Medical Systems, Inc.'s InfinixTM DP-i X-ray system provides clinicians with the ability to transition between cardiac and peripheral work seamlessly.

1 Jun 2011

ACLU and Planned Parenthood sue South Dakota

Planned Parenthood and the American Civil Liberties Union filed suit in federal court charging that a South Dakota abortion law set to take effect July 1st violates both free speech rights and a woman's right to obtain an abortion.

1 Jun 2011

New imaging method using fluorescent nanotubes can peer clearly into living mouse's innards

Developing drugs to combat or cure human disease often involves a phase of testing with mice, so being able to peer clearly into a living mouse's innards has real value.

30 May 2011

Novel treatment safe and effective for patients with intracerebral hemorrhage

A new treatment that treats a subset of stroke patients by combining minimally invasive surgery, an imaging technique likened to "GPS for the brain," and the clot-busting drug t-PA appears to be safe and effective, according to a multicenter clinical trial led by Johns Hopkins researchers.

30 May 2011

Pro-Pharmaceuticals announces name change to Galectin Therapeutics

Pro-Pharmaceuticals, Inc. today announced that it has changed its name to Galectin Therapeutics Inc. to more accurately reflect the Company's core expertise in galectin science and its leading platform for the creation of galectin inhibitors to treat serious diseases including fibrosis and cancer.

27 May 2011

ImmunoGen's clinical data on IMGN901 and SAR3419 to be presented at ASCO 2011

ImmunoGen, Inc., a biotechnology company that develops targeted antibody-based anticancer products using its antibody expertise and Targeted Antibody Payload (TAP) technology, today announced that favorable clinical data on two ImmunoGen-created TAP compounds - IMGN901 and SAR3419 - are being presented at the ASCO 2011 Annual Meeting taking place in Chicago, IL, June 4-8, 2011.

26 May 2011

Boehringer Ingelheim's new afatinib-cetuximab phase Ib data in NSCLC presented at ASCO 2011

Boehringer Ingelheim Pharmaceuticals, Inc. will present new phase Ib data at the 2011 American Society of Clinical Oncology annual meeting in Chicago that indicates combining its investigational therapy afatinib with cetuximab at the maximum tested dose controlled disease in all (n=22) treated epidermal growth factor receptor (EGFR)-mutation positive patients with non-small cell lung cancer who developed acquired resistance to treatment with a reversible EGFR tyrosine kinase inhibitor.

26 May 2011

Study finds evidence that pelvis does continue to widen throughout a person's lifetime

By the age of 20, most people have reached skeletal maturity and do not grow any taller. Until recently it was assumed that skeletal enlargement elsewhere in the body also stopped by age 20.

26 May 2011

DTU purchases T-Ray 4000 system from Picometrix for terahertz time-domain studies

Advanced Photonix, Inc. today announced that the Lyngby campus of The Technical University of Denmark has purchased a T-Ray 4000 from its wholly-owned subsidiary, Picometrix, for terahertz time-domain studies.

24 May 2011

Asymptomatic patients do not benefit from CT angiography screening

Coronary computed tomographic angiography, which can detect plaque buildup in heart vessels, is sometimes used as a screening tool to assess the risk for a heart attack. However, the usefulness of the test on low-risk patients who do not have coronary symptoms, such as chest pain, has been unclear.

24 May 2011

TZ Medical, Cinterion announce Aera-CT mHealth heart arrhythmia monitoring device

Cinterion, the global leader in cellular machine-to-machine communication modules and a Gemalto company, and TZ Medical, a leading manufacturer of critical-care medical products, today announced Aera-CT, a lightweight and cost effective mHealth heart arrhythmia monitoring device.

24 May 2011

VBL to present updated VB-111 Phase 1 trial results in advanced metastatic cancer at ASCO 2011

VBL Therapeutics, a clinical-stage biotechnology company committed to the development of novel treatments for immune-inflammatory diseases and cancer, today announced that it will present updated results for a Phase 1 study of VB-111 in patients with advanced metastatic cancer at the upcoming Annual Meeting of the American Society of Clinical Oncology, taking place June 3-7, 2011, at McCormick Place in Chicago.

24 May 2011

First quad-channel, 16-bit ADC for medical imaging applications

Texas Instruments Incorporated today introduced the first quad-channel, 16-bit analog-to-digital converter (ADC) for medical imaging applications, such as magnetic resonance imaging (MRI).

23 May 2011

CT News and Research

GE Healthcare to highlight advanced portfolio of molecular imaging technologies at SNM meeting

Response Genetics' clinical approaches to improve cancer care to be presented at ASCO 2011

Ipilimumab and bevacizumab drugs effective in treating metatastic melanoma

Mild brain injury tracked using special MRI technique

PCF funds 14 new Creativity Awards for advanced prostate cancer research

Adipose-derived stem cell procedure restores skull defects after brain surgery

Adaptimmune announces opening of Phase I/II clinical trial in multiple myeloma

Twelve interventional live cases to use Toshiba's Infinix DP-i X-ray system at NCVH conference

ACLU and Planned Parenthood sue South Dakota

New imaging method using fluorescent nanotubes can peer clearly into living mouse's innards

Novel treatment safe and effective for patients with intracerebral hemorrhage

Pro-Pharmaceuticals announces name change to Galectin Therapeutics

ImmunoGen's clinical data on IMGN901 and SAR3419 to be presented at ASCO 2011

Boehringer Ingelheim's new afatinib-cetuximab phase Ib data in NSCLC presented at ASCO 2011

Study finds evidence that pelvis does continue to widen throughout a person's lifetime

DTU purchases T-Ray 4000 system from Picometrix for terahertz time-domain studies

Asymptomatic patients do not benefit from CT angiography screening

TZ Medical, Cinterion announce Aera-CT mHealth heart arrhythmia monitoring device

VBL to present updated VB-111 Phase 1 trial results in advanced metastatic cancer at ASCO 2011

First quad-channel, 16-bit ADC for medical imaging applications

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

How Omics Technologies Are Transforming Biological Research and Drug Discovery

Latest News